WEDNESDAY, Aug. 22, 2018 -- For patients with melanoma and untreated brain metastases, nivolumab combined with ipilimumab shows clinically meaningful efficacy, according to a study published in the Aug. 23 issue of the New England Journal of...
Original Article: Nivolumab + Ipilimumab Shows Efficacy for Untreated Brain Mets